ArticleCancers2022

Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles.

Tomonori Araki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.